Japanese AIDS Vaccine To Be Clinically Tested In U.S. In '10 (Japan)
This article was originally published in PharmAsia News
A Japanese consortium including the University of Tokyo, Dnavec, and the National Institute of Infectious Diseases plans to begin clinical testing of its AIDS vaccine as early as 2010. The consortium hopes to commercialize the vaccine around 2015. The nasal spray vaccine effort will mark the first such testing of a Japanese-developed AIDS vaccine. Researchers expect the vaccine to increase the number of immune cells available to attack cells infected by HIV. The consortium found that HIV did not propagate among 60% of monkeys given the vaccine prior to being exposed to the virus. The International AIDS Vaccine Initiative will organize clinical tests involving several dozen healthy people. If the vaccine's safety and effectiveness are borne out by those tests, larger scale clinical tests will be carried out. (Click here for more - May Require Paid Subscription
You may also be interested in...
The UK's Advertising Standards Authority will closely monitor the marketing communications of dietary supplements e-tailer Health Solutions after it failed to provide a substantive response to health claims regulation breaches.
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.